PAKISTAN’S PERSPECTIVE ON COVID-19 VACCINES

IF 0.5 Q3 MEDICINE, GENERAL & INTERNAL Gomal Journal of Medical Sciences Pub Date : 2021-09-30 DOI:10.46903/gjms/19.03.1016
Taimoor Hassan, Saleha Saleha
{"title":"PAKISTAN’S PERSPECTIVE ON COVID-19 VACCINES","authors":"Taimoor Hassan, Saleha Saleha","doi":"10.46903/gjms/19.03.1016","DOIUrl":null,"url":null,"abstract":"As of May 10, 2021, the entire planet has reported approximately 188 million COVID-19 cases, with 2.54 million fatalities. Initially, lockdowns and softening measures have been thrown into turmoil throughout the world since the outbreak. Our social life will only return to normal once an appropriate vaccine is produced and proper authorized preventive techniques are implemented. To tackle this pandemic, governments and health experts all around the globe are experimenting with a range of measures and preventative strategies. Certain nations are considered to be more successful than others in terms of providing safety to their inhabitants and increasing their economic activities. A plethora of vaccinations have been produced, and a research anthology has been published. However, medical personnel are still searching for a viable treatment to limit this pandemic. Till date, only 5 vaccines have been approved by WHO for emergency use that includes Pfizer-BioNTech, Moderna, AstraZeneca, Sinopharm, Johnson & Johnson. Currently, confusing information about the COVID-19 vaccination is being disseminated across the world. During health emergency, rumors spread and caused panic, insanity, and anxiety. SARS-CoV-2 strains, on the other hand, are constantly appearing over the world. This article provides a Pakistan’s perspective towards COVID-19 vaccines with an updated review.","PeriodicalId":44174,"journal":{"name":"Gomal Journal of Medical Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gomal Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46903/gjms/19.03.1016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

As of May 10, 2021, the entire planet has reported approximately 188 million COVID-19 cases, with 2.54 million fatalities. Initially, lockdowns and softening measures have been thrown into turmoil throughout the world since the outbreak. Our social life will only return to normal once an appropriate vaccine is produced and proper authorized preventive techniques are implemented. To tackle this pandemic, governments and health experts all around the globe are experimenting with a range of measures and preventative strategies. Certain nations are considered to be more successful than others in terms of providing safety to their inhabitants and increasing their economic activities. A plethora of vaccinations have been produced, and a research anthology has been published. However, medical personnel are still searching for a viable treatment to limit this pandemic. Till date, only 5 vaccines have been approved by WHO for emergency use that includes Pfizer-BioNTech, Moderna, AstraZeneca, Sinopharm, Johnson & Johnson. Currently, confusing information about the COVID-19 vaccination is being disseminated across the world. During health emergency, rumors spread and caused panic, insanity, and anxiety. SARS-CoV-2 strains, on the other hand, are constantly appearing over the world. This article provides a Pakistan’s perspective towards COVID-19 vaccines with an updated review.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
巴基斯坦对新冠肺炎疫苗的展望
截至2021年5月10日,全球已报告约1.88亿例新冠肺炎病例,死亡254万人。最初,自疫情爆发以来,封锁和软化措施在世界各地陷入混乱。只有生产出适当的疫苗并实施适当的授权预防技术,我们的社会生活才会恢复正常。为了应对这一流行病,全球各国政府和卫生专家正在试验一系列措施和预防策略。在为居民提供安全和增加经济活动方面,某些国家被认为比其他国家更成功。已经生产了大量的疫苗,并出版了一本研究选集。然而,医务人员仍在寻找一种可行的治疗方法来限制这一流行病。到目前为止,只有5种疫苗被世界卫生组织批准紧急使用,其中包括辉瑞-BioNTech、莫德纳、阿斯利康、国药集团和强生。目前,有关新冠肺炎疫苗接种的令人困惑的信息正在世界各地传播。在突发卫生事件期间,谣言不断传播,引发恐慌、精神错乱和焦虑。另一方面,严重急性呼吸系统综合征冠状病毒2型毒株不断出现在世界各地。本文提供了巴基斯坦对新冠肺炎疫苗的看法和最新评论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gomal Journal of Medical Sciences
Gomal Journal of Medical Sciences MEDICINE, GENERAL & INTERNAL-
CiteScore
0.60
自引率
80.00%
发文量
37
审稿时长
40 weeks
期刊最新文献
PREVALENCE AND DETERMINANTS OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN PERINATAL ASPHYXIA POPULATION OF DISTRICT MARDAN, PAKISTAN EPITHELIOID SARCOMA OF WRIST IN 52 YEARS OLD FEMALE IN CHENNAI, INDIA PREVALENCE OF PHENOTYPIC CARBAPENEM-RESISTANT ENTEROBACTERALES ISOLATES AND THEIR DISTRIBUTION BY SEX, AGE GROUPS, STATE AND SPECIES IN SOUTH-EAST NIGERIA PREVALENCE OF RIFAMPICIN RESISTANCE AND PROBES IDENTIFICATION OF 81BP RRDR RPO-B GENE IN PULMONARY TUBERCULOSIS PATIENTS OF DISTRICT BANNU, PAKISTAN METHOTREXATE TOXICITY AS MYELOSUPPRESSION IN 66-YEAR-OLD FEMALE WITH RHEUMATOID ARTHRITIS IN CHENNAI, TAMIL NADU, INDIA
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1